Fidson Healthcare Approves N3.6bn Dividend Amid Growth

At the 27th Annual General Meeting held virtually, shareholders of Fidson Healthcare Plc approved a dividend of N1.50 per 50 kobo ordinary share, totaling N3.6 billion. This approval coincided with the one-year anniversary of a leadership transition at the Board and Management levels, which shareholders recognized as a testament to the company's strong corporate governance and succession planning.

Dr. Fidelis Ayebae, Founder and Chairman, stated that 2025 would be a defining year for Fidson, which achieved a revenue milestone of N119.06 billion, becoming the first pharmaceutical company in Nigeria to surpass the N100 billion annual revenue mark.

Ayebae expressed gratitude to the Federal Government for improving the operating environment for local manufacturers. Mr.

Biola Adebayo, Managing Director/Chief Executive Officer, reaffirmed the company's commitment to growth through innovation and strategic investments, aiming to enhance manufacturing capabilities and market penetration while delivering value to stakeholders.